200 participants
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2026-04-15
- Completion:
- 2030-08-30
Conditions
- Multiple Myeloma
Interventions
- DRUG
No Results Yet